N-terminal pro-Brain natriuretic peptide as a useful biomarker for monitoring prognosis in patients with cardiac valve replacement

Journal of Clinical Laboratory Analysis

Volumn 25, Issue 3, 2011, Pages 149-155

  Cai, Bei ^a   Wang, Lanlan ^a   Liu, Jin ^a   Shi, Yingkang ^a   Guo, Yingqiang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Cardiac valve replacement; N terminal pro brain natriuretic peptide; NT proBNP; Rheumatic heart diseases

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CONGENITAL HEART DISEASE; FEMALE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART VALVE REPLACEMENT; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROGNOSIS; RHEUMATIC HEART DISEASE; SINUS ARRHYTHMIA;

ARRHYTHMIAS, CARDIAC; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; FEMALE; HEART FUNCTION TESTS; HEART VALVE PROSTHESIS; HEART VALVES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PERIOPERATIVE CARE; POSTOPERATIVE CARE; PROGNOSIS; ROC CURVE;

EID: 79955909192     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20435     Document Type: Article

References (23)

1. Lainchbury JG, Campbell E, Frampton CM, et al. Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 2003;42:728-735.
2. Cai B, Wang L L, Liu J, et al. The Effectiveness of NT-proBNP in diagnosing heart failure. Chin J Evid Based Med 2005;5:224-228.
3. Nielsen LS, Svanegaard J, Klitgaard NA, et al. N-terminal pro-brain natriuretic peptide for discriminating between cardiac and non-cardiac dyspnoea. Eur J Heart Fail 2004;6:63-70.
4. Mueller C, Scholer A, Laule-Kilian K, et al. Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea. N Engl J Med 2004;350:647-654.
5. Iwanaga Y, Nishi I, Furuichi S, et al. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: Comparison between systolic and diastolic heart failure. J Am Coll Cardiol 2006;47:742-748.
6. Watanabe S, Shite J, Takaoka H, et al. Myocardial stiffness is an important determinant of the plasma brain natriuretic peptide concentration in patients with both diastolic and systolic heart failure. Eur Heart J 2006;27:832-838.
7. Troughton RW, Prior DL, Pereira JJ, et al. Plasma B-type natriuretic peptide levels in systolic heart failure. Importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol 2004;43:416-422.
8. Berendes E, Schmidt C, Van Aken H, et al. A-type and B-type natriuretic peptides in cardiac surgical procedures. Anesth Analg 2004;98:11-19.
9. Saribulbul O, Alat I, Coskun S, et al. The role of brain natriuretic peptide in the prediction of cardiac performance in coronary artery bypass grafting. Tex Heart Inst J 2003;30:298-304.
10. Georges A, Forestier F, Valli N, et al. Changes in type B natriuretic peptide (BNP) concentrations during cardiac valve replacement. Eur J Cardiothorac Surg 2004;25:941-945.
11. Mekontso-Dessap A, Tual L, Kirsch M, et al. B-type natriuretic peptide to assess haemodynamic status after cardiac surgery. Br J Anaesth 2006;97:777-782.
12. Hall C. Essential biochemistry and physiology of (NT-pro) BNP. Eur J Heart Fail 2004;6:257-260.
13. Pudil R, Tichý M, Praus R, et al. NT-proBNP and echocardiographic parameters in patients with acute heart failure. Acta Medica (Hradec Kralove) 2007;50:51-56.
14. Tretjak M, Verovnik F, Benko D, et al. Tissue Doppler velocities of mitral annulus and NT-proBNP in patients with heart failure. Eur J Heart Fail 2005;7:520-524.
15. Sleilaty G, Madi-Jebara S, Yazigi A, et al. Brain Natriuretic Peptide (BNP) Variations in Cardiac Surgery Patients. Anesthesiology 2004;101:A250.
16. Reyes G, Forés G, Rodríguez-Abella RH, et al. NT-proBNP in cardiac surgery: A new tool for the management of our patients? Interact Cardiovasc Thorac Surg 2005;4:242-247.
17. Avidan MS, Meehan N, Ponte J, et al. Changes in brain natriuretic peptide concentrations following open cardiac surgery with cardioplegic cardiac arrest. Clin Chim Acta 2001;303:127-132.
18. Piper SN, Kumle B, Rohm KD, et al. Influence of cardiopulmonary bypass [CPB] on the natriuretic peptides ANP and BNP. A comparison between long and short duration of CPB and off pump surgery. Anasthesiol Intensivmed Notfallmed Schmerzther 2003;38:463-469.
19. Rafał K, Andrzej M, Piotr B, et al. The dynamics of perioperative changes in serum BNP and troponin I concentrations in patients undergoing heart-valve correction with extracorporeal circulation. Adv Clin Exp Med 2007;16:383-388.
20. Leuchte HH, Holzapfel M, Baumgartner RA, et al. Characterization of of brain natriuretic peptide in long-term follow-up of pulmonary arterial hypertesion. Chest 2005;128:2368-2374.
21. Fijalkowska A, Kurzyna M, Torbicki A, et al. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest 2006;129:1313-1321.
22. Leuchte HH, Holzapfel M, Baumgartner RA, et al. Clinical significance of brain natriuretic peptide in primary pulmonary hypertension. J Am Coll Cardiol 2004;43:764-770.
23. Shelton RJ, Clark AL, Goode K, et al. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structure heart disease in patients with atrial fibrillation. Eur Heart J 2006;27:2353-2361.